Risk-adapted Omission of Systematic Cores in PI-RADS 3 Lesions Based on Prostate-specific Antigen Density, Biopsy Route, and Targeted Core Number: A Multicentre Cohort Study.

Buhas BA, Mjaess G, Diamand R, Peyrottes A, Uleri A, Baboudjian M, Brown JA, Abou Chakra M, Borz MB, Crisan N, Baudewyns A, Jabbour T, Jeglinschi S, Iancu M, Ploussard G

Open source

DOI
10.1016/j.euo.2026.07.003
Published
2026 Jul 30
Container
European urology oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.euo.2026.07.003,
  title = {Risk-adapted Omission of Systematic Cores in PI-RADS 3 Lesions Based on Prostate-specific Antigen Density, Biopsy Route, and Targeted Core Number: A Multicentre Cohort Study.},
  author = {Buhas BA and Mjaess G and Diamand R and Peyrottes A and Uleri A and Baboudjian M and Brown JA and Abou Chakra M and Borz MB and Crisan N and Baudewyns A and Jabbour T and Jeglinschi S and Iancu M and Ploussard G},
  year = {2026},
  journal = {European urology oncology},
  doi = {10.1016/j.euo.2026.07.003},
  url = {https://doi.org/10.1016/j.euo.2026.07.003}
}

RIS

TY  - JOUR
TI  - Risk-adapted Omission of Systematic Cores in PI-RADS 3 Lesions Based on Prostate-specific Antigen Density, Biopsy Route, and Targeted Core Number: A Multicentre Cohort Study.
AU  - Buhas BA
AU  - Mjaess G
AU  - Diamand R
AU  - Peyrottes A
AU  - Uleri A
AU  - Baboudjian M
AU  - Brown JA
AU  - Abou Chakra M
AU  - Borz MB
AU  - Crisan N
AU  - Baudewyns A
AU  - Jabbour T
AU  - Jeglinschi S
AU  - Iancu M
AU  - Ploussard G
PY  - 2026
JO  - European urology oncology
DO  - 10.1016/j.euo.2026.07.003
UR  - https://doi.org/10.1016/j.euo.2026.07.003
ER  - 

APA

BA, B., G, M., R, D., A, P., A, U., M, B., JA, B., M, A. C., MB, B., N, C., A, B., T, J., S, J., M, I., & G, P. (2026). Risk-adapted Omission of Systematic Cores in PI-RADS 3 Lesions Based on Prostate-specific Antigen Density, Biopsy Route, and Targeted Core Number: A Multicentre Cohort Study.. European urology oncology. https://doi.org/10.1016/j.euo.2026.07.003

Source records